|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/37 | (2006.01) |
| A61K 38/37 | (2013.01) | ||
| A61P 7/04 | (2006.01) | ||
| A61P 7/04 | (2018.01) |
| (11) | Number of the document | 3641800 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18737505.0 |
| Date of filing the European patent application | 2018-06-22 | |
| (97) | Date of publication of the European application | 2020-04-29 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/066696 |
| Date | 2018-06-22 |
| (87) | Number | WO 2018/234518 |
| Date | 2018-12-27 |
| (30) | Number | Date | Country code |
| 17177477 | 2017-06-22 | EP | |
| 18153579 | 2018-01-26 | EP |
| (72) |
VERHAGEN, Anne , AU
PESTEL, Sabine , DE
WEIMER, Thomas , DE
HOFMANN, Marco , DE
HUYNH, Huy , AU
MARASKOVSKY, Eugene , AU
|
| (73) |
CSL Behring Lengnau AG ,
Biotech Innovation Park, 2543 Lengnau BE,
CH
|
| (54) | MODULATION OF FVIII IMMUNOGENICITY BY TRUNCATED VWF |
| MODULATION OF FVIII IMMUNOGENICITY BY TRUNCATED VWF |